Login / Signup

Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.

Vianney GruzelleHélène Guet-RevilletChristine SegondsStéphanie BuiJulie MaceyRaphaël ChironMarine MicheletMarlène Murris-EspinMarie Mittaine
Published in: BMC pulmonary medicine (2020)
Pending these studies, we propose, due to possible spontaneous clearance, to check the presence of Burkholderia 1 month after PC before starting antibiotics, at least in the milder cases, and to evaluate a combination of intravenous beta-lactam + oral or intravenous fluoroquinolone + inhaled aminoglycoside.
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • high dose
  • lung function
  • acinetobacter baumannii
  • gram negative
  • multidrug resistant
  • drug resistant
  • genetic diversity